• By Wayne Eskridge, President & CEO, Fatty Liver Foundation  |  Jul 3, 2019

    NASH: A Disease without Symptoms but Lots of Hope

    What if you had a liver disease but nobody told you until it was too late? Typically, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are silent diseases. They have no symptoms. Even if cirrhosis has developed, there are often no symptoms until the liver has become so damaged…more.

    Categories: General, MASH
  • By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Feb 13, 2019

    NASH: Fighting a Silent Epidemic

    Consider the liver. It’s just one of the jumble of stuff inside that makes us tick, right? What do you really know about it though—other than it’s “vital?” In fact, the liver is your largest internal organ, and plays vital roles in neutralizing toxins, fighting infections, manufacturing proteins and hormones,…more.

    Categories: General, MASH
  • By Linda Barlow  |  Jul 30, 2013

    Targeted Therapies Open Door to Improved Outcomes and Lower Costs to Treat HCV

    As we were reminded on World Hepatitis Day, early detection is critical to turning the tide of this “silent epidemic” that impacts millions. However, strategies to end the deadly effects of viral hepatitis don’t stop there. Personalized treatment is another essential tool that fuels better outcomes for patients with hepatitis C (HCV) while…more.

  • By Linda Barlow  |  Jul 23, 2013

    World Hepatitis Day Spotlights Importance of Early Detection to Improve Prevention and Treatment Strategies

    This Sunday, July 28, is World Hepatitis Day, an observance that reminds us that hepatitis (inflammation of the liver) remains largely unknown as a major health threat. Approximately half a billion people worldwide and 4.4 million people in the U.S. live with chronic viral hepatitis, with one million deaths resulting…more.